[Oocyte activation with calcium ionophore A23187 and puromycin on human oocytes that fail to fertilize after intracytoplasmic sperm injection]. 2006

Qun Lu, and Zi-jiang Chen, and Xuan Gao, and Shui-ying Ma, and Mei Li, and Jing-mei Hu, and Yuan Li
Reproductive Medicine Center, Shandong Provincial Hospital, Shandong University, Jinan 250021, China.

OBJECTIVE To investigate the effect of assisted oocyte activation with calcium ionophore A23187 and puromycin on human oocytes that fail to fertilize after intracytoplasmic sperm injection (ICSI). METHODS All 113 discarded oocytes that showed no evidence of fertilization at 16 - 18 hours after in vitro maturation (IVM)-ICSI cycles and conventional ICSI were assigned to four groups according to the time after ICSI: IVM-ICSI 22-hour group (n = 33), IVM-ICSI 44-hour group (n = 18), ICSI 44-hour group (n = 37) and ICSI 68-hour group (n = 25). All unfertilized oocytes were exposed to calcium ionophore A23187 (5 micromol/L) for 5 minutes and subsequently incubated with puromycin (10 microg/ml) for 4 hours. After incubation, the oocytes were cultured in vitro for 3 - 5 days. The activation rate, proportion of oocytes that showed pronucleus formation and cleavage rate were calculated after activation. Sex chromosomal analysis was performed by dual color fluorescence in situ hybridization (FISH) on the embryos that displayed two pronuclei and a second polar body. RESULTS The combination of calcium ionophore A23187 with puromycin could activate the unfertilized oocytes 22 - 68 hours after ICSI. Best results were achieved in IVM-ICSI 22-hour group, which elicited 88% (29/33) of activation rate, 62% (18/29) of cleavage rate and 28% (5/18) of 4-cell embryos. One embryo in this group developed to the morular stage. The activation rate and developmental potential of the activated embryos in IVM-ICSI 44-hour group, ICSI 44-hour group and ICSI 68-hour group decreased. FISH analysis showed 4 embryos with XX and 9 embryos with XY in 16 embryos. CONCLUSIONS The combination of calcium ionophore A23187 with puromycin could effectively activate unfertilized oocytes 22 - 68 hours after ICSI. The cultured time of unfertilized oocytes after ICSI affects activation efficiency and developmental potential of the activated embryos. The activated zygotes that display two pronuclei and a second polar body can develop normally.

UI MeSH Term Description Entries
D007476 Ionophores Chemical agents that increase the permeability of biological or artificial lipid membranes to specific ions. Most ionophores are relatively small organic molecules that act as mobile carriers within membranes or coalesce to form ion permeable channels across membranes. Many are antibiotics, and many act as uncoupling agents by short-circuiting the proton gradient across mitochondrial membranes. Ionophore
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008297 Male Males
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D011691 Puromycin A cinnamamido ADENOSINE found in STREPTOMYCES alboniger. It inhibits protein synthesis by binding to RNA. It is an antineoplastic and antitrypanosomal agent and is used in research as an inhibitor of protein synthesis. CL-13900,P-638,Puromycin Dihydrochloride,Puromycin Hydrochloride,Stylomycin,CL 13900,CL13900,P 638,P638
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002970 Cleavage Stage, Ovum The earliest developmental stage of a fertilized ovum (ZYGOTE) during which there are several mitotic divisions within the ZONA PELLUCIDA. Each cleavage or segmentation yields two BLASTOMERES of about half size of the parent cell. This cleavage stage generally covers the period up to 16-cell MORULA. Segmentation Stage, Ovum,Cleavage Stages, Ovum,Ovum Cleavage Stage,Ovum Cleavage Stages,Ovum Segmentation Stage,Ovum Segmentation Stages,Segmentation Stages, Ovum
D004622 Embryo, Mammalian The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS. Embryonic Structures, Mammalian,Mammalian Embryo,Mammalian Embryo Structures,Mammalian Embryonic Structures,Embryo Structure, Mammalian,Embryo Structures, Mammalian,Embryonic Structure, Mammalian,Embryos, Mammalian,Mammalian Embryo Structure,Mammalian Embryonic Structure,Mammalian Embryos,Structure, Mammalian Embryo,Structure, Mammalian Embryonic,Structures, Mammalian Embryo,Structures, Mammalian Embryonic
D005260 Female Females
D005307 Fertilization in Vitro An assisted reproductive technique that includes the direct handling and manipulation of oocytes and sperm to achieve fertilization in vitro. Test-Tube Fertilization,Fertilizations in Vitro,In Vitro Fertilization,Test-Tube Babies,Babies, Test-Tube,Baby, Test-Tube,Fertilization, Test-Tube,Fertilizations, Test-Tube,In Vitro Fertilizations,Test Tube Babies,Test Tube Fertilization,Test-Tube Baby,Test-Tube Fertilizations

Related Publications

Qun Lu, and Zi-jiang Chen, and Xuan Gao, and Shui-ying Ma, and Mei Li, and Jing-mei Hu, and Yuan Li
July 2001, Fertility and sterility,
Qun Lu, and Zi-jiang Chen, and Xuan Gao, and Shui-ying Ma, and Mei Li, and Jing-mei Hu, and Yuan Li
September 1999, Fertility and sterility,
Qun Lu, and Zi-jiang Chen, and Xuan Gao, and Shui-ying Ma, and Mei Li, and Jing-mei Hu, and Yuan Li
January 2023, La Clinica terapeutica,
Qun Lu, and Zi-jiang Chen, and Xuan Gao, and Shui-ying Ma, and Mei Li, and Jing-mei Hu, and Yuan Li
July 2009, Fertility and sterility,
Qun Lu, and Zi-jiang Chen, and Xuan Gao, and Shui-ying Ma, and Mei Li, and Jing-mei Hu, and Yuan Li
January 2021, Frontiers in endocrinology,
Qun Lu, and Zi-jiang Chen, and Xuan Gao, and Shui-ying Ma, and Mei Li, and Jing-mei Hu, and Yuan Li
July 2012, Reproductive medicine and biology,
Qun Lu, and Zi-jiang Chen, and Xuan Gao, and Shui-ying Ma, and Mei Li, and Jing-mei Hu, and Yuan Li
March 1994, Human reproduction (Oxford, England),
Qun Lu, and Zi-jiang Chen, and Xuan Gao, and Shui-ying Ma, and Mei Li, and Jing-mei Hu, and Yuan Li
May 1990, Journal of reproduction and fertility,
Qun Lu, and Zi-jiang Chen, and Xuan Gao, and Shui-ying Ma, and Mei Li, and Jing-mei Hu, and Yuan Li
December 1997, Equine veterinary journal. Supplement,
Qun Lu, and Zi-jiang Chen, and Xuan Gao, and Shui-ying Ma, and Mei Li, and Jing-mei Hu, and Yuan Li
June 2006, The Journal of reproductive medicine,
Copied contents to your clipboard!